Comment

. 2021 Jun;82(6):e29-e30.

doi: 10.1016/j.jinf.2021.03.004. Epub 2021 Mar 17.

Details of SARS-CoV-2 reinfections at a major UK tertiary centre

Mark I Garvey¹, Anna L Casey², Martyn A C Wilkinson³, Liz Ratcliffe⁴, Claire McMurray⁵, Joanne Stockton⁶, Elisabeth Holden⁷, Husam Osman⁸, Nick J Loman⁹

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom; Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom.
² University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: anna.casey@uhb.nhs.uk.
³ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: martyn.wilkinson@uhb.nhs.uk.
⁴ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: liz.Ratcliffe@uhb.nhs.uk.
⁵ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom. Electronic address: C.L.McMurray@bham.ac.uk.
⁶ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom. Electronic address: J.D.Stockton@bham.ac.uk.
⁷ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: elisabeth.holden@uhb.nhs.uk.
⁸ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: Husam.osman@uhb.nhs.uk.
⁹ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom.

PMID: 33744302
PMCID: PMC7965844
DOI: 10.1016/j.jinf.2021.03.004

Comment

Details of SARS-CoV-2 reinfections at a major UK tertiary centre

Mark I Garvey et al. J Infect. 2021 Jun.

. 2021 Jun;82(6):e29-e30.

doi: 10.1016/j.jinf.2021.03.004. Epub 2021 Mar 17.

Authors

Mark I Garvey¹, Anna L Casey², Martyn A C Wilkinson³, Liz Ratcliffe⁴, Claire McMurray⁵, Joanne Stockton⁶, Elisabeth Holden⁷, Husam Osman⁸, Nick J Loman⁹

Affiliations

¹ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom; Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom.
² University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: anna.casey@uhb.nhs.uk.
³ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: martyn.wilkinson@uhb.nhs.uk.
⁴ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: liz.Ratcliffe@uhb.nhs.uk.
⁵ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom. Electronic address: C.L.McMurray@bham.ac.uk.
⁶ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom. Electronic address: J.D.Stockton@bham.ac.uk.
⁷ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: elisabeth.holden@uhb.nhs.uk.
⁸ University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Edgbaston, Birmingham B15 2WB, United Kingdom. Electronic address: Husam.osman@uhb.nhs.uk.
⁹ Institute of Microbiology and Infection, The University of Birmingham, Edgbaston, Birmingham, United Kingdom.

PMID: 33744302
PMCID: PMC7965844
DOI: 10.1016/j.jinf.2021.03.004

No abstract available

Keywords: COVID-19; Re-infections; whole genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest None.

Comment on

Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection.
Hanrath AT, Payne BAI, Duncan CJA. Hanrath AT, et al. J Infect. 2021 Apr;82(4):e29-e30. doi: 10.1016/j.jinf.2020.12.023. Epub 2020 Dec 26. J Infect. 2021. PMID: 33373652 Free PMC article.

Cited by

COVID-19 false dichotomies and a comprehensive review of the evidence regarding public health, COVID-19 symptomatology, SARS-CoV-2 transmission, mask wearing, and reinfection.
Escandón K, Rasmussen AL, Bogoch II, Murray EJ, Escandón K, Popescu SV, Kindrachuk J. Escandón K, et al. BMC Infect Dis. 2021 Jul 27;21(1):710. doi: 10.1186/s12879-021-06357-4. BMC Infect Dis. 2021. PMID: 34315427 Free PMC article. Review.
SARS-CoV-2 Reinfection Is a New Challenge for the Effectiveness of Global Vaccination Campaign: A Systematic Review of Cases Reported in Literature.
Lo Muzio L, Ambosino M, Lo Muzio E, Quadri MFA. Lo Muzio L, et al. Int J Environ Res Public Health. 2021 Oct 19;18(20):11001. doi: 10.3390/ijerph182011001. Int J Environ Res Public Health. 2021. PMID: 34682746 Free PMC article.
Elucidating reasons of COVID-19 re-infection and its management strategies.
Jain VK, Iyengar K, Garg R, Vaishya R. Jain VK, et al. Diabetes Metab Syndr. 2021 May-Jun;15(3):1001-1006. doi: 10.1016/j.dsx.2021.05.008. Epub 2021 May 7. Diabetes Metab Syndr. 2021. PMID: 33989898 Free PMC article. Review.
SARS-CoV-2 reinfections during the first three major COVID-19 waves in Bulgaria.
Marinov GK, Mladenov M, Rangachev A, Alexiev I. Marinov GK, et al. PLoS One. 2022 Sep 9;17(9):e0274509. doi: 10.1371/journal.pone.0274509. eCollection 2022. PLoS One. 2022. PMID: 36084070 Free PMC article.
Reinfection in patients with COVID-19: a systematic review.
Ren X, Zhou J, Guo J, Hao C, Zheng M, Zhang R, Huang Q, Yao X, Li R, Jin Y. Ren X, et al. Glob Health Res Policy. 2022 Apr 29;7(1):12. doi: 10.1186/s41256-022-00245-3. Glob Health Res Policy. 2022. PMID: 35488305 Free PMC article.

See all "Cited by" articles

References

1. Tillett R.L., Sevinsky J.R., Hartley P.D., et al. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet. 2020;21:52–58. - PMC - PubMed
1. Hanrath A.T., Payne B.A.I., Duncan C.J.A. Prior SARS-CoV-2 infection is associated with protection against symptomatic reinfection. J Infect. 2020 doi: 10.1016/j.jinf.2020.12.023. - DOI - PMC - PubMed
1. Callow K.A., Parry H.F., Sergeant M., Tyrrell D.A. The time course of the immune response to experimental coronavirus infection of man. Epidemiol Infect. 1990;105:435–446. - PMC - PubMed
1. Sabino E.C., Buss L.F., Carvalho M.P.S., et al. Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. Lancet. 2021;397(10273):P452–P455. - PMC - PubMed
1. Public Health England (PHE) Guidance. COVID-19: Management of Staff and Exposed Patients or Residents in Health and Social Care Settings. Available at: https://www.gov.uk/government/publications/covid-19-management-of-expose... (last accessed 23rd February 2021)

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
Other Literature Sources
- scite Smart Citations
Medical
- MedlinePlus Health Information
Miscellaneous
- NCI CPTAC Assay Portal

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Details of SARS-CoV-2 reinfections at a major UK tertiary centre

Affiliations

Details of SARS-CoV-2 reinfections at a major UK tertiary centre

Authors

Affiliations

Conflict of interest statement

Comment on

Similar articles

Cited by

References

Publication types

MeSH terms

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Miscellaneous